Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), sold 3,129 shares at $12.33 ($38K) on 2007-07-03, disclosed to the SEC on 2007-07-06.
Open-market sale of $38k SLXP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.29 | 1,300 | $16K | 41.5% |
| 2 | $12.30 | 1,029 | $13K | 32.9% |
| 3 | $12.31 | 400 | $5K | 12.8% |
| 4 | $12.32 | 300 | $4K | 9.6% |
| 5 | $12.33 | 100 | $1K | 3.2% |
| Total | $12.30 avg | 3,129 |
| $38K |
| 100% |
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |